TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
+6.06%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$195M
AUM Growth
+$195M
(-60%)
Cap. Flow
-$274M
Cap. Flow
% of AUM
-140.53%
Top 10 Holdings %
Top 10 Hldgs %
73.17%
Holding
37
New
9
Increased
2
Reduced
10
Closed
15
Top Buys
| 1 |
McKesson
MCK
|
$18.1M |
| 2 |
Soleno Therapeutics
SLNO
|
$16.8M |
| 3 |
Cigna
CI
|
$10.9M |
| 4 |
Gilead Sciences
GILD
|
$10M |
| 5 |
Illumina
ILMN
|
$9.58M |
Top Sells
| 1 |
Zimmer Biomet
ZBH
|
$39M |
| 2 |
Natera
NTRA
|
$32.1M |
| 3 |
argenx
ARGX
|
$23.9M |
| 4 |
VRNA
Verona Pharma
VRNA
|
$21.1M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$20.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Novo Nordisk
NVO
$252B
| – | – |
-209,984
| Closed | -$18.1M |
|
|
27
Natera
NTRA
$23B
| – | – |
-202,646
| Closed | -$32.1M |
|
28
MindMed
MNMD
$689M
| – | – |
-820,793
| Closed | -$5.71M |
|
29
LivaNova
LIVN
$3.09B
| – | – |
-99,700
| Closed | -$4.62M |
|
30
Legend Biotech
LEGN
$6.64B
| – | – |
-388,704
| Closed | -$12.6M |
|
31
Jazz Pharmaceuticals
JAZZ
$7.99B
| – | – |
-161,812
| Closed | -$19.9M |
|
32
Janux Therapeutics
JANX
$1.38B
| – | – |
-236,407
| Closed | -$12.7M |
|
33
Idexx Laboratories
IDXX
$50.7B
| – | – |
-44,972
| Closed | -$18.6M |
|
34
Geron
GERN
$893M
| – | – |
-2,472,836
| Closed | -$8.75M |
|
35
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-355,366
| Closed | -$20.1M |
|
36
Biohaven
BHVN
$1.71B
| – | – |
-140,220
| Closed | -$5.24M |
|
|
AVDL
37
Avadel Pharmaceuticals
AVDL
$1.42B
| – | – |
-1,937,984
| Closed | -$20.4M |
|